NPY1R
MOLECULAR TARGETneuropeptide Y receptor Y1
NPY1R (neuropeptide Y receptor Y1) is targeted by 21 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting NPY1R
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | neuropeptide y | 2.08 | 7 |
| 2 | Peptide YY | 1.61 | 4 |
| 3 | Cilostazol | 1.39 | 3 |
| 4 | paxilline | 1.39 | 3 |
| 5 | Carvedilol | 1.10 | 2 |
| 6 | 2-Chloroadenosine 2-Chloroadenosine. | 0.69 | 1 |
| 7 | Azauridine | 0.69 | 1 |
| 8 | Bombesin | 0.69 | 1 |
| 9 | Bufexamac | 0.69 | 1 |
| 10 | Chlorhexidine | 0.69 | 1 |
| 11 | Crizotinib | 0.69 | 1 |
| 12 | Digitoxin | 0.69 | 1 |
| 13 | Digoxin | 0.69 | 1 |
| 14 | Diphenhydramine | 0.69 | 1 |
| 15 | Hexachlorophene | 0.69 | 1 |
| 16 | Misoprostol | 0.69 | 1 |
| 17 | Nadolol | 0.69 | 1 |
| 18 | Ouabain | 0.69 | 1 |
| 19 | Pindolol | 0.69 | 1 |
| 20 | Propafenone | 0.69 | 1 |
| 21 | Triiodothyronine | 0.69 | 1 |
About NPY1R as a Drug Target
NPY1R (neuropeptide Y receptor Y1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 21 compounds with documented NPY1R interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
NPY1R inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.